Hacker News Reader

Of course it is self serving. I am optimistic for progress in medicine with the help of AI in general as well, not optimistic for antrophic.

View on HN

Exactly. The reality is that spitting out drug candidates is already the “easy” part… the harder part is getting that candidate through clinical trials, which is where 90% of such journeys end.

As always Anthropic is saying literally anything if it gets them closer to the giant bucket of money that is the IPO.

So getting drug candidates with high success rate actually is the hard part.

If the candidates were better, then <90% would end their journeys at the clinical trials. Though that's not to say that they've provided any real evidence that their candidates actually are better yet

Many times issues with clinical trials is not a technical one, it's a human one, practitioners unwilling to test, patients that stop showing up, red tape, committees, denial of consent, etc. I do not see how AI as it stands currently can solve those issues.

Reply on news.ycombinator.com